Cellphire Therapeutics CLPH-511 Fast Track Designation Granted
ROCKVILLE, Md., March 17, 2025 (GLOBE NEWSWIRE) -- Cellphire Therapeutics, Inc., a clinical stage biotechnology company developing next-generation allogeneic, platelet-derived, cellular therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for CLPH-511 (Frozen Activated Platelets) Injectable Suspension for the treatment of acute hemorrhage as an alternative to conventional platelets when not available or in short supply.
Fast Track designation, granted under section 506(b) of the Federal Food, Drug, and Cosmetic Act (FDCA), is designed to expedite the development and review of drugs that address serious conditions and have the potential to fill an unmet medical need. The designation allows Cellphire Therapeutics to engage in more frequent communication with the FDA, facilitating a more efficient path toward regulatory approval. Additionally, Fast Track status enables the company to take advantage of rolling review for its Biologics License Application (BLA), which allows submission and review of a portion of the BLA prior to the application being complete. Products with Fast Track Designation could also be eligible for Priority Review at the time of BLA submission, if clinical data demonstrates a significant improvement in safety or efficacy.
'This Fast Track designation recognizes CLPH-511's potential to address the unmet need of acute hemorrhage and Cellphire looks forward to continued collaboration with FDA to get this product to patients that need it as soon as possible', said Damien Bates, CMO of Cellphire Therapeutics.
Acute hemorrhage remains a leading cause of morbidity and mortality in trauma, surgery, and critical care settings. Platelet transfusions are essential in managing severe bleeding, but logistical challenges, including short shelf life and limited availability, often hinder timely access. CLPH-511, a frozen and activated platelet product, is designed to overcome these limitations by providing a readily available, long-lasting alternative that can be deployed in both civilian and military settings.
The use of CLPH-511 in acute hemorrhage is currently being investigated in a Phase 2/3 adaptive design study, titled 'Randomized Controlled Trial Comparing Dimethyl Sulfoxide Cryopreserved Platelets to Liquid Stored Platelets in Patients Undergoing Cardiopulmonary Bypass Surgery' (CRYPTICS - NCT04709705).
Cellphire Therapeutics will continue to advance the clinical development of CLPH-511, leveraging the benefits of this Fast Track designation to bring this innovative therapy to patients as quickly and efficiently as possible.
For more information on the CRYPTICS study, visit ClinicalTrials.gov.
About Cellphire Therapeutics
Cellphire Therapeutics, Inc.'s vision: No one should die from controllable hemorrhage. A private, clinical stage biotechnology company developing next-generation, allogeneic, platelet-derived therapies, Cellphire has a portfolio of platelet-derived biologics including two assets in clinical development: its late-stage biologic CLPH-511, a cryopreserved platelet (CPP) therapy with extended shelf life, and CLPH-211, part of the FPH® family of freeze-dried, platelet-derived hemostatic agents. Once approved, Cellphire's differentiated technologies will address significant unmet health system and medical needs across various clinical settings including acute bleeding associated with surgery, trauma and traumatic brain injury. For more information, visit www.Cellphire.com.
This CPP Project is supported by the US Army Medical Research and Development Command under Contract No. W81XWH20C0030. The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation.
Contact:
Robert Woods
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
New program teaches students to become electricians
SPRINGFIELD, Mo. — Midwest Technical Institute held a grand opening for its new program, aimed at teaching those who want to become electricians. 'I went and joined the program. I've been having a blast ever since I joined,' Student Austin Massey said. Massey is just one of several students taking part in the course. 'This is my first introduction to electrical in general, residential, commercial, all that,' Massey said. For him, it's been a neat experience. 'It's really cool to learn all the intricate stuff about electrical and why stuff works and why buildings are powered and everything and all that fun stuff,' Massey added. Program Director/Instructor Shelby Obermann says they keep students busy by teaching them from their code book or with hands-on training. 'Today, the students are working on grounding and bonding,' Obermann said. 'They're essentially just kind of going over everything that we've learned about these past couple of weeks.' The program helps by turning students into apprentices, just one step in the journey, and helping address a workforce shortage of electricians nationwide. 'It's a seven month program, just gives you an entry level position to be able to go out there as an apprentice and apply the skills and stuff like that that you're learning here, both code book and hands-on, because I am 100% implementing more hands-on than just bookwork,' Obermann said. That shortage is something Brian Turmail, with the Association of General Contractors of America, says the industry desperately needs to address. '[Based on our survey] in Missouri alone, two-thirds of contractors say they're having a hard time finding enough electricians to hire to keep pace with demand,' Turmail said. Turmail says one of the reasons for the shortage is that a lot of students are pursuing four-year degrees, rather than going through trade schools. 'The shortest answer is mothers don't want their babies to grow up to be construction workers in this country,' Turmail said. 'We're encouraged by what we see in programs like [MTI's].' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
Where did 100,000 registered vehicles go in Shelby County?
MEMPHIS, Tenn. — Here's a shocking statistic for you: There are 100,000 fewer registered vehicles on the roads in Shelby County this year than there were last year, according to Shelby County Mayor Lee Harris. 'Right now there are just under 600K vehicles in Shelby County, which is about a 100k drop from 12 months ago, and we need to make up that revenue this budget cycle,' Mayor Harris said in a recent budget presentation. That's a 17% drop in one year, and it's causing the county to lose millions in revenue. The question is, why? Harris proposed a $5 increase in county car registration fees to make up the difference, but couldn't explain where the vehicles went. 'This $5 increase will allow us to manage the unexpected drop in revenue we have seen, and the sudden and inexplicable reduction in the number of vehicles that are now registered in Shelby County,' Harris said. Mayor proposes tax cut in new Shelby County budget We have reached out to Shelby County Commissioners on their thoughts and are currently waiting to hear back, but state Rep. Mark White sees the drop off in car registration as a big problem. 'Something is missing there that is going unregistered, and that's causing the city of Memphis and Shelby County millions of dollars in lost revenue,' said White (R-Memphis). 'It's critical and we will have to find a solution to this.' White sees Shelby County Clerk Wanda Halbert as the problem. Many, including White, have tried to oust Halbert from her position. In January, the city failed to collect $7 million in additional driver registration fees, which created a shortfall in the city budget. White says he hopes voters come to the polls to make change in the midterms. Rep. Justin Pearson, NAACP aim to halt xAI project in Memphis 'I keep hoping that they bring in the right management, but that's an elected position,' White said. 'We've taken this all the way to the courts and the courts have dismissed it. … Now the citizens of Memphis are going to have to vote, and make sure you know who you are voting for to put the proper person in an office to run that.' WREG has requested an interview with Halbert, and we are currently working on scheduling that. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
MyChart access returning to Kettering Health patients: Update
DAYTON, Ohio (WDTN) — More systems are returning to normal operation as Kettering Health continues to recover from the May 20 cyberattack. According to Kettering Health officials, MyChart is once again available to patients with nearly all of its functionality. Kettering Health patients speak out on aftermath of cyberattack Patients can use MyChart to schedule and view upcoming appointments, view prescription lists, message providers and view test results. Kettering Health says patients may receive extra notifications from MyChart as they continue to restore patient data to EPIC, their electronic medical record system. 'This process— called 'backfill'— updates patient records in real time. When that happens, MyChart automatically sends text and email notifications to let you know,' said Kettering Health. Officials remind patients to remain vigilant when reviewing any digital communications, as there are still reports of several scams surfacing after the cyberattack. For more information and frequently asked questions, visit Kettering Health's website. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
